US Bancorp DE Trims Stock Holdings in Oscar Health, Inc. $OSCR

Key Points

• US Bancorp DE dramatically decreased its holdings in Oscar Health, Inc. by 84.6% in the first quarter, now owning just 3,088 shares valued at approximately $40,000.
• Institutional investors and hedge funds collectively own 75.70% of Oscar Health's stock, with several firms significantly increasing their positions during the same period.
• Oscar Health reported a 29.0% year-over-year revenue increase but posted a net EPS of ($0.89), which slightly surpassed analyst expectations.

US Bancorp DE lessened its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 84.6% in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 3,088 shares of the company's stock after selling 16,963 shares during the period. US Bancorp DE's holdings in Oscar Health were worth $40,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in OSCR. Raymond James Financial Inc. purchased a new stake in Oscar Health during the fourth quarter valued at about $6,613,000. Summit Investment Advisors Inc. grew its position in Oscar Health by 5.8% during the fourth quarter. Summit Investment Advisors Inc. now owns 20,838 shares of the company's stock valued at $280,000 after acquiring an additional 1,141 shares during the period. Barclays PLC grew its position in Oscar Health by 10.8% during the fourth quarter. Barclays PLC now owns 361,062 shares of the company's stock valued at $4,852,000 after acquiring an additional 35,244 shares during the period. NewEdge Advisors LLC grew its position in Oscar Health by 9,811.2% during the fourth quarter. NewEdge Advisors LLC now owns 99,112 shares of the company's stock valued at $1,332,000 after acquiring an additional 98,112 shares during the period. Finally, Dimensional Fund Advisors LP grew its position in Oscar Health by 10.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,448,703 shares of the company's stock valued at $46,353,000 after acquiring an additional 313,227 shares during the period. Hedge funds and other institutional investors own 75.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on the company. Wells Fargo & Company downgraded Oscar Health from an "equal weight" rating to an "underweight" rating and lowered their price target for the company from $16.00 to $10.00 in a research report on Friday, July 11th. Robert W. Baird reissued a "neutral" rating and set a $14.00 price target (down previously from $28.00) on shares of Oscar Health in a research report on Friday, July 25th. Baird R W downgraded Oscar Health from a "strong-buy" rating to a "hold" rating in a research report on Friday, July 25th. Barclays decreased their target price on Oscar Health from $17.00 to $11.00 and set an "underweight" rating for the company in a research report on Wednesday, July 23rd. Finally, Piper Sandler decreased their target price on Oscar Health from $14.00 to $13.00 and set a "neutral" rating for the company in a research report on Thursday, August 14th. Four research analysts have rated the stock with a Hold rating and five have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Oscar Health has a consensus rating of "Strong Sell" and a consensus price target of $12.07.

Oscar Health Stock Up 8.9%

Shares of NYSE OSCR traded up $1.3720 on Friday, hitting $16.7920. The company had a trading volume of 19,331,859 shares, compared to its average volume of 19,934,982. Oscar Health, Inc. has a 12-month low of $11.20 and a 12-month high of $23.79. The business has a 50 day moving average of $16.12 and a two-hundred day moving average of $14.80. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $4.34 billion, a P/E ratio of -20.73 and a beta of 1.86.

Oscar Health (NYSE:OSCR - Get Free Report) last issued its earnings results on Wednesday, August 6th. The company reported ($0.89) earnings per share for the quarter, topping the consensus estimate of ($0.90) by $0.01. The company had revenue of $2.86 billion during the quarter, compared to the consensus estimate of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The company's revenue was up 29.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.20 earnings per share. As a group, equities research analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.